Active Ingredient History
Glutamate carboxypeptidase II (GCPII), also known as N-acetyl-L-aspartyl-L-glutamate peptidase I, NAAG peptidase, or prostate-specific membrane antigen (PSMA) is an enzyme that in humans is encoded by the FOLH1 gene. Human GCPII contains 750 amino acids and weighs approximately 84 kDa. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Biliary Tract Neoplasms (Phase 1)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 1)
Colorectal Neoplasms (Phase 1)
Endometrial Neoplasms (Phase 1)
Esophageal Neoplasms (Phase 1)
Gallbladder Neoplasms (Phase 1)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Kidney Diseases (Phase 1)
Liver Neoplasms (Phase 1)
Melanoma (Phase 1)
Mesothelioma (Phase 1)
Neuroendocrine Tumors (Phase 1)
Osteosarcoma (Phase 1)
Ovarian Diseases (Phase 1)
Pancreatic Neoplasms (Phase 1)
Prostate (Phase 1)
Prostatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 1)
Sarcoma (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Stomach Neoplasms (Phase 1)
Testicular Neoplasms (Phase 1)
Thyroid Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
